Dr. Niamtu’s Weblog

….on cosmetic facial surgery

Merz European Expert Injector Summit: Berlin, Germany

Some of the “crew” at Checkpoint Charlie in Berlin

I am writing this blog flying back across the Atlantic Ocean after attending the Merz European Injector Expert Summit in Berlin, Germany.  This was a great meeting and also the first time in years that I traveled internationally and did not have to work on a lecture.  It was a strange feeling not to be ramming through PowerPoint for numerous talks.  So, I actually got a lot of catch up work done including working on some articles and before and after pictures that were stacking up

I was honored to be part of the American contingency of well-known aesthetic experts from dermatology, plastic surgery, facial plastic surgery, and other specialties.  You can’t hang around with the likes of dermatologists Mario Bussa, Oscar Hevia, Derek Jones, Heidi Waldorf, Phil Werschler, Tina Funt, Rhoda Narins, facial plastic surgeons  Amir Moradi, Steven H. Dayan, Timothy C. Flynn, and plastic surgeons  Paul Lorenc, Brian Kinney, David Funt and Michael Kane and not learn something.  Keeping this group together and on track from Merz Aesthetics were Dennis Condon, Brian Pilcher, Jennifer Redmond and Wendy Johnson.  These people are the ultimate professionals and their knowledge of fillers and neurotoxins is amazing.  Besides this, they all have shining personalities.

The fellowship was awesome and again, you can’t hang out with a group of master injectors like this and not come back without pearls.  One great highlight was having the unique opportunity to tour the Merz plant where the neurotoxin Xeomin is produced.  The efficiency, sterility and automation of this facility was unbelievable and everyone that completed this tour now understands neurotoxins a little better.  In addition, we had the opportunity to learn more about the Merz company and their century of innovation.

A pleasant surprise that occurred on the trip was the announcement by the FDA that Belotero has received approval.  This now gives doctors and patients a new option for treating superficial wrinkles and the tear trough region.  Due to the unique arrangement of the filler particles in Belotero, it is well suited for superficial injection in the tear trough region without worrying about creating the bluish coloration under the skin knows as the Tyndall Effect.

The academic presentations were all high tech and it was very interesting seeing experts from all over the world discuss their means of treating aging with Xeomin, Radiesse and Belotero.  Although there was good spirited discussion and disagreement (what do you expect from a group of world experts), I was impressed that injection is pretty much approached the same all around the world.   The live injection sessions were particularly interesting as any injector will always admit that he or she leans something (good or bad) by watching other experts inject.

Berlin is a beautiful city and we all (as a group) had the ability to visit several world class museums and drink some world class beer!  I can’t think of the last time I packed so much learning and fun in over a 4 day period.  Sitting in yet another airport, can’t wait to go to work tomorrow and operate and inject.

Like all meetings, the meeting was as good as the people you met and to that end, this meeting was priceless.

To learn more about Xeomin and cosmetic facial surgery by Dr. Joe Niamtu, III DMD in Richmond, Virginia, visit www.lovethatface.com

Joe Niamtu, III DMD

Cosmetic Facial Surgery

Richmond, Virginia

www.lovethatface.com

Advertisements

November 21, 2011 Posted by | Bolotero, Uncategorized, Xeomin | , , | Leave a comment

Dr. Niamtu appointed to Xeomin Teaching Faculty

xeomin

The introduction of Botox by Allergan in the 1990’s proved to be a paradigm shift in cosmetic surgery as it was a safe and easy treatment that worked and had no previous type of treatment.  Obviously Botox was the first and still the
most popular neurotoxin (now called neuromodulator) with millions of treatments all over the world.  Like any industry,
progress introduces competition and several years ago Medicis introduced their product Dysport which although not exactly the same drug as Botox, has the same results.  Dysport has caught on and is a popular option for some patients that prefer it to Botox for various reasons, one of them being it is a little less expensive.  Dr. Niamtu is recognized as a Key Opinion Leader (KOL) in cosmetic facial surgery and serves on the teaching faculty   Botox and Dysport.  In addition, he is the only Diamond Level Botox provider in Richmond and the largest solo injector in Virginia (he personally performs all injections).

Dr. Niamtu is proud to be a member of the Xeomin (Merz Aesthetics) teaching faculty.  He has recently returned from Berlin, Germany completing instructor training for Xeomin and also had the rare opportunity to tour the actual plant where Xeomin
is produced.  He, along with other Key Opinion Leaders in plastic surgery and dermatology, will be teaching Xeomin
injection techniques to physicians in the USA.

Xeomin is the third neuromodulator to be FDA approved in this country and will represent yet another option for patients seeking
improvement of facial wrinkles.  Xeomin has been used around the world for safe and effective treatment of facial wrinkles since 1995. Although all these products are technically known as botulinum toxin A, they all have slightly different chemical structures.  Xeomin is the first neuromodulator that is processed in a manner to eliminate a part of the molecule known as the accessory protein coat.  It is this protein that contributes to allergic reactions.  Users of Xeomin can expect the same results as Botox or Dysport although the initial price will probably be less.  Otherwise the products are administered the same and have the same results that last the same amount of time.  The number of units injected with Xeomin is compatible with Botox injections.

Dr. Niamtu is pleased and honored to be included in the international teaching faculty for Xeomin and is excited to be the first doctor in Richmond to offer this treatment in his practice. Consumers should be prepared for the release of more new neuromodulators that are in the FDA pipeline and just like the different fillers, the multiple neuromodulators will offer more options for patients.  For more information about Xeomin or cosmetic
facial surgery visit www.lovethatface.com

Joe Niamtu, III DMD

Cosmetic Facial Surgery

Richmond, Virginia

 

November 10, 2011 Posted by | Botox, Minimally Invasive Cosmetic Facial Surgery, New Cosmetic Surgery Technology, Uncategorized, Xeomin | , , , | Leave a comment